Gamma Glutamyl Transferase

References

• Webb EC. Enzyme nomenclature 1992: recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the nomenclature and classification of enzymes. San Diego: Academic Press. 1992.
   Google Scholar
• Shaw LM, Stromme JH, London JL, et al. International Federation of Clinical Chemistry. Scientific Committee. Analytical Section. Expert Panel on Enzymes. IFCC methods for measurement of enzymes. Part 4. IFCC methods for gamma-glutamyltransferase [(gamma-glutamyl)-peptide: amino acid gamma-glutamyltransferase, EC 2.3.2.2]. IFCC Document, Stage 2, Draft 2, 1983-01 with a view to an IFCC Recommendation. Clin Chim Acta 1983; 135: 315F-338F.
   Google Scholar
• Rosalki SB. Gamma-glutamyl transpeptidase. Adv Clin Chem 1975; 17: 53–107.
   Google Scholar
• Goldberg DM. Structural, functional, and clinical aspects of gamma-glutamyltransferase. CRC Crit Rev Clin Lab Sci 1980; 12: 1–58.
   Google Scholar
• Nemesanszky E, Lott JA. Gamma-glutamyltransferase and its isoenzymes: progress and problems. Clin Chem 1985; 31: 797–803.
   Google Scholar
• Lieberman MW, Barrios R, Carter BZ, et al. Gamma-Glutamyl transpeptidase. What does the organization and expression of a multipromoter gene tell us about its functions? Am J Pathol 1995; 147: 1175–85.
   Google Scholar
• Wolf S, Gassen HG. Gamma-glutamyl transpeptidase, a blood-brain barrier associated membrane protein. Splitting peptides to transport amino acids. Adv Exp Med Biol 1997; 421: 3745.
   Google Scholar
• Taniguchi N, Ikeda Y. gamma-Glutamyl transpeptidase: catalytic mechanism and gene expression. Adv Enzymol Relat Areas Mol Biol 1998; 72: 239–78.
   Google Scholar
• Hanigan MH. gamma-Glutamyl transpeptidase, a glutathionase: its expression and function in carcinogenesis. Chem Biol Interact 1998; 111-112: 333–42.
   Google Scholar
• Ristoff E, Larsson A. Patients with genetic defects in the gamma-glutamyl cycle. Chem Biol Interact 1998; 24: 111–21.
   Google Scholar
• Sakai H, Sakabe N, Sasaki K, et al. A preliminary description of the crystal structure of gamma-glutamyltranspeptidase from E. coli K-12. JBiochem (Tokyo) 1996; 120: 26–8.
   Google Scholar
• Xu K, Strauch MA. Identification, sequence, and expression of the gene encoding gamma-glutamyltranspeptidase in Bacillus subtilis. J Bacteriol 1996; 178: 4319–22.
   Google Scholar
• Osuji GO. The disintegration of yam tuber gamma-glutamyl transpeptidase during tuber storage. Acta Biol Med Ger 1981; 40: 1497–501.
   Google Scholar
• Martin MN, Slovin JP. Purified gamma-glutamyl transpeptidases from tomato exhibit high affinity for glutathione and glutathione S-conjugates. Plant Physiol 2000; 122: 1417–26.
   Google Scholar
• Hussein AS, Walter RD. Purification and characterization of gamma-glutamyl transpeptidase from Ascaris suum. Mol Biochem Parasitol 1996; 77: 41–7
   Google Scholar
• Figlewicz DA, Delattre O, Guellaen G, et al. Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. Genomics 1993; 17: 299–305
   Google Scholar
• Collins JE, Mungall AJ, Badcock KL, et al. The organization of the gamma-glutamyl transferase genes and other low copy repeats in human chromosome 22q11. Genome Res 1997; 7: 522–31.
   Google Scholar
• Chikhi N, Holic N, Guellaen G, et al. Gamma-glutamyl transpeptidase gene organization and expression: a comparative analysis in rat, mouse, pig and human species. Comp Biochem Physiol B Biochem Mol Biol 1999; 122: 367–80.
   Google Scholar
• Shi ZZ, Habib GM, Lebovitz RM, et al. Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. Gene 1995; 167: 233–7.
   Google Scholar
• Visvikis A, Pawlak A, Accaoui MJ, et al. Structure of the 5' sequences of the human gamma-glutamyltransferase gene. Eur J Biochem 2001; 268: 317–325.
   Google Scholar
• Kok PJ, Seidel B, Holtkamp HC, et al. A new procedure for the visualization of multiple forms of gamma-glutamyl transferase (GGT). Results in normals, patients receiving enzyme-inducing drugs and patients having liver parenchymal lesions. Clin Chim Acta 1978; 90: 209–16.
   Google Scholar
• Lilja H, Jeppsson JO, Kristensson H. Evaluation of serum gamma-glutamyltransferase by electrofocusing, and variations in isoform patterns. Clin Chem 1983; 29: 1034–7.
   Google Scholar
• Selvaraj P, Balasubramanian KA. Comparative structural and lectin-binding studies on gamma-glutamyltransferase from human adult liver, fetal liver and primary hepatoma. Eur J Biochem 1985; 153: 485–90.
   Google Scholar
• Delanghe JR, De Buyzere ML, De Scheerder IK, et al. Lectin-affinity chromatography of serum gamma-glutamyltransferase in liver disease. Clin Chim Acta 1987; 162: 311–8.
   Google Scholar
• Delanghe JR, De Buyzere ML, De Scheerder IK, et al. Activation energy and lectin affinity chromatography of gamma-glutamyltransferase as a marker for enzyme heterogeneity. Clin Biochem 1989; 22: 115–9.
   Google Scholar
• Huseby NE. Multiple forms of serum gamma-glutamyltransferase. Association of the enzyme with lipoproteins. Clin Chim Acta 1982; 124: 103–12.
   Google Scholar
• Artur Y, Wellman-Bednawska M, Jacquier A, et al. Complexes of serum gamma-glutamyltransferase with apolipoproteins and immunoglobulin A. Clin Chem 1984; 30: 631–3.
   Google Scholar
• Grostad M, Huseby NE. Clearance of different multiple forms of human gamma-glutamyltransferase. Clin Chem 1990; 36: 1654–6.
   Google Scholar
• Hanigan MH, Frierson HF. Immunohistochemical detection of g-glutamyl transpeptidase in normal human tissue. JHistochem Cytochem 1996; 44: 1101–1108.
   Google Scholar
• Shiozawa M, Hiraoka Y, Yasuda K, et al. Synthesis of human gamma-glutamyl transpeptidase (GGT) during the fetal development of liver. Gene 1990; 87: 299–303.
   Google Scholar
• Moniz C, Nicolaides KH, Keys D, et al. Gamma-glutamyl transferase activity in fetal serum, maternal serum, and amniotic fluid during gestation. J Clin Pathol 1984; 37: 700–3.
   Google Scholar
• Zhang HF, Ong WY, Leong SK, et al. Species differences in the localisation of gamma-glutamyl transpeptidase immunopositive cells at the blood-brain interface. J Brain Res 1997; 38: 323–30.
   Google Scholar
• Garcion E, Sindji L, Leblondel G, et al. 1,25-dihydroxyvitamin D3 regulates the synthesis of gamma-glutamyl transpeptidase and glutathione levels in rat primary astrocytes. J Neurochem 1999; 73: 859–66.
   Google Scholar
• Novogrodsky A, Tate SS, Meister A. gamma-Glutamyl transpeptidase, a lymphoid cell-surface marker: relationship to blastogenesis, differentiation, and neoplasia. Proc Natl Acad Sci US A 1976; 73: 2414–8.
   Google Scholar
• Miller AM, Sandler E, Kobb SM, et al. Hematopoietic growth factor induction of gamma-glutamyl transferase in the KG-1 myeloid cell line. Exp Hematol 1993; 21: 9–15.
   Google Scholar
• Grisk O, Kuster U, Ansorge S. The activity of gamma-glutamyl transpeptidase (gamma-GT) in populations of mononuclear cells from human peripheral blood. Biol Chem Hoppe Seyler 1993; 374: 287–90.
   Google Scholar
• Nichols TC, Guthridge JM, Karp DR, et al. Gamma-glutamyl transpeptidase, an ecto-enzyme regulator of intracellular redox potential, is a component of TM4 signal transduction complexes. Eur J Immunol 1998; 28: 4123–9.
   Google Scholar
• Henson SE, Nichols TC, Holers VM, et al. The ectoenzyme gamma-glutamyl transpeptidase regulates antiproliferative effects of S-nitrosoglutathione on human T and B lymphocytes. J Immunol 1999; 163: 1845–52.
   Google Scholar
• Szasz G. A kinetic photometric method for serum gamma-glutamyl transpeptidase. Clin Chem 1969; 15: 124–136.
   Google Scholar
• Rhone DP, White FM. Effects of storage in the cold on activity of gamma-glutamyltransferase in serum. Clin Chem 1976; 22: 103–4.
   Google Scholar
• Heerspink W, Hafkenscheid JCM, Siepel H, et al. Temperature-converting factors for enzymes: comparison of methods. Enzyme 1980; 25: 333–341.
   Google Scholar
• Masuike M, Ogawa M, Kitahara T, et al. Development of radioimmunoassay for gamma-glutamyl transferase using pancreatic enzyme. Ann Clin Biochem 1983; 20: 247–50.
   Google Scholar
• Rosalki SB, Nemesanszky E, Foo AY. A new fluorescence method for gamma-glutamyltransferase isoenzyme demonstration. Ann Clin Biochem 1981; 18: 25–7.
   Google Scholar
• De-Oliveira IM, Fujimori E, Pereira VG, et al. DL-methionine supplementation of rice-and-bean diets affects gamma-glutamyltranspeptidase activity and glutathione content in livers of growing rats. Braz J Med Biol Res 1999; 32: 483–8.
   Google Scholar
• Speisky H, Shackel N, Varghese G, et al. Role of hepatic gamma-glutamyltransferase in the degradation of circulating glutathione: studies in the intact guinea pig perfused liver. Hepatology 1990; 11: 843–9.
   Google Scholar
• Moriya S, Nagata S, Yokoyama H, et al. Expression of gamma-glutamyl transpeptidase mRNA after depletion of glutathione in rat liver. Alcohol Alcohol 1994; 29 Suppl 1: 107–11.
   Google Scholar
• O'Daley, S. An abnormal sulphydryl compound in urine. Irish J Med Sci 1968, 7: 578–579.
   Google Scholar
• Goodman SI, Mace JW, Pollack S. Serum gamma-glutamyl transpeptidase deficiency. Lancet 1971; 1: 234–5
   Google Scholar
• Wright EC, Stern J, Ersser R, et al. Glutathionuria: gamma-glutamyl transpeptidase deficiency. J Inherit Metab Dis 1980; 2: 3–7.
   Google Scholar
• Hammond JW, Potter M, Wilcken B, et al. Siblings with gamma-glutamyltransferase deficiency. J Inherit Metab Dis 1995; 18: 82–3.
   Google Scholar
• Lieberman MW, Wiseman AL, Shi ZZ, et al. Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. Proc Natl Acad Sci US A 1996; 93: 7923–6.
   Google Scholar
• Harding CO, Williams P, Wagner E, et al. Mice with genetic gamma-glutamyl transpeptidase deficiency exhibit glutathionuria, severe growth failure, reduced life spans, and infertility. J Biol Chem 1997; 272: 12560–7.
   Google Scholar
• Hammond JW, Potter M, Sim KG, et al. Reduced glutathione, gamma-glutamylcysteine, cysteine and gamma-glutamylglutamine in gamma-glutamyltransferase deficiency. J Inherit Metab Dis 1999; 22: 235–9.
   Google Scholar
• Habib GM, Shi ZZ, Ou CN, et al. Altered gene expression in the liver of gamma-glutamyl transpeptidase-deficient mice. Hepatology 2000; 32: 556–62.
   Google Scholar
• Jean JC, Harding CO, Oakes SM, et al. gamma-Glutamyl transferase (GGT) deficiency in the GGTenu1 mouse results from a single point mutation that leads to a stop codon in the first coding exon of GGT mRNA. Mutagenesis 1999; 14: 31–6.
   Google Scholar
• Ballatori N, Wang W, Lieberman MW. Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. Am J Pathol 1998; 152: 1049–55.
   Google Scholar
• Rojas E, Valverde M, Kala SV, et al. Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. Mutat Res 2000 14; 447: 305–16.
   Google Scholar
• Will Y, Fischer KA, Horton RA, et al. gamma-glutamyltranspeptidase-deficient knockout mice as a model to study the relationship between glutathione status, mitochondrial function, and cellular function. Hepatology 2000; 32: 740–9.
   Google Scholar
• Kumar TR, Wiseman AL, Kala G, et al. Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. Endocrinology 2000; 141: 4270–4277.
   Google Scholar
• Chevez-Barrios P, Wiseman AL, Rojas E, et al. Cataract development in gamma-glutamyl transpeptidase-deficient mice. Exp Eye Res 2000; 71: 575–82.
   Google Scholar
• Hanigan MH, Frierson HF, Swanson PE, et al. Altered expression of gamma-glutamyl transpeptidase in human tumors. Hum Pathol 1999; 30: 300–5.
   Google Scholar
• Durham JR, Frierson HF, Hanigan MH. Gamma-glutamyl transpeptidase immunoreactivity in benign and malignant breast tissue. Breast Cancer Res Treat 1997; 45: 55–62.
   Google Scholar
• Hanigan MH, Frierson HF, Brown JE, et al. Human ovarian tumors express gamma-glutamyl transpeptidase. Cancer Res 1994; 54: 286–90.
   Google Scholar
• Schaff Z, Kovalszky I, Nagy P, et al. Human and experimental hepatocarcinogenesis. Scand J Gastroenterol Suppl 1998; 228: 90–7.
   Google Scholar
• Gallagher BC, Rudolph DB, Hinton BT, et al. Differential induction of gamma-glutamyl transpeptidase in primary cultures of rat and mouse hepatocytes parallels induction during hepatocarcinogenesis. Carcinogenesis 1998; 19: 1251–5.
   Google Scholar
• Tsutsumi M, Sakamuro D, Takada A, et al. Detection of a unique gamma-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: a new candidate for early diagnosis of hepatocellular carcinoma. Hepatology 1996; 23: 1093–7.
   Google Scholar
• Yao D, Jiang D, Huang Z, et al. Abnormal expression of hepatoma specific gamma-glutamyl transferase and alteration of gamma-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma. Cancer 2000; 88: 761–9.
   Google Scholar
• Hanigan MH. Expression of gamma-glutamyl transpeptidase provides tumor cells with a selective growth advantage at physiologic concentrations of cyst(e)ine. Carcinogenesis 1995; 16: 181–5.
   Google Scholar
• Hochwald SN, Harrison LE, Rose DM, et al. gamma-Glutamyl transpeptidase mediation of tumor glutathione utilization in vivo. J Natl Cancer Inst 1996; 88: 193–7.
   Google Scholar
• Schadendorf D, Jurgovsky K, Kohlmus CM, et al. Glutathione and related enzymes in tumor progression and metastases of human melanoma. J Invest Dermatol 1995; 105: 109–12.
   Google Scholar
• Hanigan MH, Gallagher BC, Townsend DM, et al. Gamma-glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo. Carcinogenesis 1999; 20: 553–9.
   Google Scholar
• Hanigan MH, Frierson HF, Abeler VM, et al. Human germ cell tumors: expression of gamma-glutamyl transpeptidase and sensitivity to cisplatin. Br J Cancer 1999; 81: 75–9.
   Google Scholar
• Kugelman A, Choy HA, Liu R, et al. gamma-Glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells. Am JRespir Cell Mol Biol 1994; 11: 586–92.
   Google Scholar
• Liu RM, Hu H, Robison TW, et al. Increased gamma-glutamylcysteine synthetase and gamma-glutamyl transpeptidase activities enhance resistance of rat lung epithelial L2 cells to quinone toxicity. Am J Respir Cell Mol Biol 1996; 14: 192–7.
   Google Scholar
• Liu RM, Shi MM, Giulivi C, et al. Quinones increase gamma-glutamyl transpeptidase expression by multiple mechanisms in rat lung epithelial cells. Am J Physiol 1998; 274: L330–6.
   Google Scholar
• Takahashi Y, Oakes SM, Williams MC, et al. Nitrogen dioxide exposure activates gamma-glutamyl transferase gene expression in rat lung. Toxicol Appl Pharmacol 1997; 143: 388–96.
   Google Scholar
• Hybertson BM, Lee YM, Cho HG, et al. Alveolar type II cell abnormalities and peroxide formation in lungs of rats given IL-1 intratracheally. Inflammation 2000; 24: 289–303.
   Google Scholar
• Hull J, Vervaart P, Grimwood K, et al. Pulmonary oxidative stress response in young children with cystic fibrosis. Thorax 1997; 52: 557–60.
   Google Scholar
• Shi M, Gozal E, Choy HA, et al. Extracellular glutathione and gamma-glutamyl transpeptidase prevent H2O2-induced injury by 2,3-dimethoxy-1,4-naphthoquinone. Free Radic Biol Med 1993; 15: 57–67.
   Google Scholar
• Markey CM, Rudolph DB, Labus JC, et al. Oxidative stress differentially regulates the expression of gamma-glutamyl transpeptidase mRNAs in the initial segment of the rat epididymis. J Androl 1998; 19: 92–9.
   Google Scholar
• Karp DR, Shimooku K, Lipsky PE. Expression of gamma-Glutamyl Transpeptidase protects Ramos B cells from oxidation-induced cell death. J Biol Chem 2001; 276: 3798–3804.
   Google Scholar
• Hagen TM, Aw TY, Jones DP. Glutathione uptake and protection against oxidative injury in isolated kidney cells. Kidney Int 1988; 34: 74–81.
   Google Scholar
• Hagen TM, Bai C, Jones DP. Stimulation of glutathione absorption in rat small intestine by alpha-adrenergic agonists. FASEB J1991; 5: 2721–7.
   Google Scholar
• Seres T, Knickelbein RG, Warshaw JB, et al. The phagocytosis-associated respiratory burst in human monocytes is associated with increased uptake of glutathione. J Immunol 2000; 165: 3333–40.
   Google Scholar
• Stark AA. Oxidative metabolism of glutathione by gamma-glutamyl transpeptidase and per-oxisome proliferation: the relevance to hepatocarcinogenesis. A hypothesis. Mutagenesis 1991; 6: 241–5.
   Google Scholar
• Stark AA, Russell JJ, Langenbach R, et al. Localization of oxidative damage by a glutathione-gamma-glutamyl transpeptidase system in preneoplastic lesions in sections of livers from carcinogen-treated rats. Carcinogenesis 1994; 15: 343–8
   Google Scholar
• Zalit I, Glass GA, Stark AA. The role of chelators in the catalysis of glutathione-gamma-glutamyl transpeptidase-dependent lipid peroxidation by transition metals. Biochem Mol Biol Int 1996; 40: 1123–33.
   Google Scholar
• Stark AA, Glass GA. Role of copper and ceruloplasmin in oxidative mutagenesis induced by the glutathione-gamma-glutamyl transpeptidase system and by other thiols. Environ Mol Mutagen 1997; 29: 63–72.
   Google Scholar
• Glass GA, Stark AA. Promotion of glutathione-gamma-glutamyl transpeptidase-dependent lipid peroxidation by copper and ceruloplasmin: the requirement for iron and the effects of antioxidants and antioxidant enzymes. Environ Mol Mutagen 1997; 29: 73–80
   Google Scholar
• Paolicchi A, Tongiani R, Tonarelli P, et al. gamma-Glutamyl transpeptidase-dependent lipid peroxidation in isolated hepatocytes and HepG2 hepatoma cells. Free Radic Biol Med 1997; 22: 853–60.
   Google Scholar
• Drozdz R, Parmentier C, Hachad H, et al. gamma-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med 1998; 25: 786–92.
   Google Scholar
• Brown KE, Kinter MT, Oberley TD, et al. Enhanced gamma-glutamyl transpeptidase expression and selective loss of CuZn superoxide dismutase in hepatic iron overload. Free Radic Biol Med 1998; 24: 545–55.
   Google Scholar
• Paolicchi A, Minotti G, Tonarelli P, et al. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation—a potential mechanism in atherosclerosis. J Investig Med 1999; 47: 151–60.
   Google Scholar
• del Bello B, Paolicchi A, Comporti M, et al. Hydrogen peroxide produced during gamma-glutamyl transpeptidase activity is involved in prevention of apoptosis and maintainance of proliferation in U937 cells. FASEB J1999; 13: 69–79.
   Google Scholar
• Dominici S, Valentini M, Maellaro E, et al. Redox modulation of cell surface protein thiols in U937 lymphoma cells: the role of gamma-glutamyl transpeptidase-dependent H2O2 production and S-thiolation. Free Radic Biol Med 1999; 27: 623–35.
   Google Scholar
• Maellaro E, Dominici S, Del Bello B, et al. Membrane gamma-glutamyl transpeptidase activity of melanoma cells: effects on cellular H2O2 production, cell surface protein thiol oxidation and NF-kappa B activation status. J Cell Sci 2000; 113: 2671–8.
   Google Scholar
• Mijovic V, Patapiou H, Machin SJ, et al. Serum gamma-glutamyl transferase activity in volunteer blood donors. J Clin Pathol 1977; 30: 779.
   Google Scholar
• Jarvisalo J, Maatela J, Maki J, et al. Health-based reference values of the Mini-Finland Health Survey. I Serum gamma-glutamyltransferase, aspartate aminotransferase and alkaline phosphatase. Scand J Clin Lab Invest 1989; 49: 623–32.
   Google Scholar
• Manolio TA, Burke GL, Savage PJ, et al. Sex- and race-related differences in liver-associated serum chemistry tests in young adults in the CARDIA study. Clin Chem 1992; 38: 1853–9.
   Google Scholar
• Leino A, Impivaara O, Irjala K, et al. Health-based reference intervals for ALAT, ASAT and GT in serum, measured according to the recommendations of the European Committee for Clinical Laboratory Standards (ECCLS). Scand J Clin Lab Invest 1995; 55: 243–50.
   Google Scholar
• Forestier F. Some aspects of fetal biology. Fetal Ther 1987; 2: 181–7.
   Google Scholar
• Hallak M, Berry SM, Bichalski JA, et al. Fetal liver function tests: umbilical cord gamma-glutamyltransferase as a marker for fetal abnormality. Fetal Diagn Ther 1994; 9: 165–9.
   Google Scholar
• Garcia MP, Tutor JC, Sanjose ME, et al. Cord serum gamma glutamyltransferase in newborns. Clin Biochem 1987; 20: 269–73.
   Google Scholar
• Rivera A, Bhatia J, Rassin DK. Cord blood gamma glutamyl transferase activity: effect of gestational age, gender, and perinatal events. Am JPerinatol 1990; 7: 110–3.
   Google Scholar
• Schiele F, Guilmin AM, Detienne H, et al. Gamma-glutamyltransferase activity in plasma: statistical distributions, individual variations, and reference intervals. Clin Chem. 1977; 23: 1023–8.
   Google Scholar
• Mijovic V, Contreras M, Barbara J. Serum alanine aminotransferase (ALT) and gamma-glutamyltransferase (gamma-GT) activities in north London blood donors. J Clin Pathol. 1987; 40: 1340–4.
   Google Scholar
• Salgo L, Pal A. Variation in some enzymes in amniotic fluid and maternal serum during pregnancy. Enzyme 1989; 41: 101–7.
   Google Scholar
• Carter J. Liver function in normal pregnancy. AustNZJ Obstet Gynaecol 1990; 30: 296–302.
   Google Scholar
• Bacq Y, Zarka O, Brechot JF et al. Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls. Hepatology 1996; 23: 1030–4.
   Google Scholar
• Girling JC, Dow E, Smith JH. Liver function tests in pre-eclampsia: importance of comparison with a reference range derived for normal pregnancy. Br J Obstet Gynaecol 1997; 104: 246–50.
   Google Scholar
• David AL, Kotecha M, Girling JC. Factors affecting postnatal liver function tests. Br J Obstet Gynaecol 2000; 107: 1421–6.
   Google Scholar
• Haralambie G. Serum g-glutamyl transpeptidase and physical exercise. Clin Chim Acta 1976; 72: 363–9.
   Google Scholar
• Statland BE, Winkel P, Killingsworth LM. Factors contributing to intra-individual variation of serum constituents: physiological day-to-day variation in concentrations of 10 specific proteins in sera of healthy subjects. Clin Chem 1976; 22: 1635–8.
   Google Scholar
• Tayside Safe Driving Project. Problem drinking among drunk drivers. Br Med J1983; 286: 1319–1322
   Google Scholar
• Helander A, Vabo E, Levin K, et al. Intra- and interindividual variability of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume in teetotalers. Clin Chem 1998; 44: 2120–5.
   Google Scholar
• Whitfield JB, Martin NG. Individual differences in plasma ALT, AST and GGT: contributions of genetic and environmental factors, including alcohol consumption. Enzyme 1985; 33: 61–69.
   Google Scholar
• Bathum L, Petersen HC, Rosholm J-U., et al. Evidence for a substantial genetic influence on biochemical liver function tests: results from a population-based Danish twin study. Clin Chem 2001; 47: 81–87.
   Google Scholar
• Bibas M, Zampa G, Procopio A, et al. High serum gamma-glutamyltransferase concentrations in a family. N Engl J Med 1994; 330: 1832–3.
   Google Scholar
• Szczeklik E, Orlowski M, Szewczuk A. Serum g-glutamyl transpeptidase activity in liver disease. Gasrtoenterology 1961; 41: 353–359
   Google Scholar
• Ideo G, Morganti A, Dioguardi N. Gamma-glutamyl transpeptidase: a clinical and experimental study. Digestion 1972; 5: 326–36.
   Google Scholar
• Whitfield JB, Pounder RE, Neale G, et al. Serum g-glutamyl transpeptidase activity in liver disease. Gut 1972; 13: 702–8.
   Google Scholar
• Goldberg DM, Martin JV. Role of gamma-glutamyl transpeptidase activity in the diagnosis of hepatobiliary disease. Digestion 1975; 12: 232–46
   Google Scholar
• Solberg HE, Skrede S, Blomhoff JP. Diagnosis of liver diseases by laboratory results and discriminant analysis. Identification of best combinations of laboratory tests. Scand J Clin Lab Invest 1975; 35: 713–21
   Google Scholar
• Ellis G, Worthy E, Goldberg DM. Lack of value of serum gamma-glutamyl transferase in the diagnosis of hepatobiliary disease. Clin Biochem 1979; 12: 142–5
   Google Scholar
• Sheehan M, Haythorn P. Predictive values of various liver function tests with respect to the diagnosis of liver disease. Clin Biochem 1979; 12: 262–3
   Google Scholar
• Ruppin DC, Frydman MI, Lunzer MR. Value of serum gamma-glutamyltransferase activity in the diagnosis of hepatobiliary disease. Med J Aust 1982; 1: 421–4
   Google Scholar
• Adjarov D, Ivanov E. Clinical value of serum gamma-glutamyl transferase estimation in porphyria cutanea tarda. Br J Dermatol 1980; 102: 541–3.
   Google Scholar
• Moran MJ, Fontanellas A, Brudieux E, et al. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection. Hepatology 1998; 27: 584–9.
   Google Scholar
• Wolff C, Armas R, Krause P, et al. Treatment of porphyria cutanea tarda with chloroquine and its effect on associated liver disease: retrospective analysis. Rev Med Chil 1996; 124: 456–60.
   Google Scholar
• Horie Y, Tanaka K, Okano J, et al. Cimetidine in the treatment of porphyria cutanea tarda. Intern Med 1996; 35: 717–9.
   Google Scholar
• Okano J, Horie Y, Kawasaki H, et al. Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C. Hepatogastroenterology 1997; 44: 525–8.
   Google Scholar
• Ivanov E, Krustev L, Adjarov D, et al. Studies on the mechanism of the changes in serum and liver gamma-glutamyl transpeptidase activity. II. Experimental hexachlorobenzene porphyria in rabbits. Enzyme 1976; 21: 8–20.
   Google Scholar
• Adjarov D, Ivanov E, Keremidchiev D. Gamma-glutamyl transferase: a sensitive marker in experimental hexachlorobenzene intoxication. Toxicology 1982; 23: 73–7.
   Google Scholar
• Moses M, Lilis R, Crow KD, et al. Health status of workers with past exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in the manufacture of 2,4,5-trichlorophenoxyacetic acid: comparison of findings with and without chloracne. Am JInd Med 1984; 5: 161–82.
   Google Scholar
• Emmett EA, Maroni M, Jefferys J, et al. Studies of transformer repair workers exposed to PCBs: II. Results of clinical laboratory investigations. Am J Ind Med 1988; 14: 47–62.
   Google Scholar
• Sweeney MH, Calvert GM, Egeland GA, et al. Review and update of the results of the NIOSH medical study ofworkers exposed to chemicals contaminated with 2,3,7,8-tetrachlorodibenzodioxin. Teratog Carcinog Mutagen 1997-98; 17: 241–7.
   Google Scholar
• Fletcher LM, Kwoh-Gain I, Powell EE, et al. Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: an aid to diagnosis. Hepatology 1991; 13: 455–9.
   Google Scholar
• Conte D, Bolzoni P, Fraquelli M, et al. Non-alcoholic steatohepatitis. Report of five cases and review of the literature. Ital J Gastroenterol 1995; 27: 363–5.
   Google Scholar
• Laurin J, Lindor KD, Crippin JS, et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology 1996; 23: 1464–7
   Google Scholar
• Hickman PE, Lynch SV, Potter JM, et al. Gamma glutamyl transferase as a marker of liver transplant rejection. Transplantation 1994; 57 1278–80.
   Google Scholar
• Abraham SC, Furth EE. Receiver operating characteristic analysis of serum chemical parameters as tests of liver transplant rejection and correlation with histology. Transplantation 1995; 59: 740–6
   Google Scholar
• Kew MC, Wolf P, Whittaker D, et al. Tumour-associated isoenzymes of gamma-glutamyl transferase in the serum of patients with hepatocellular carcinoma. Br J Cancer 1984; 50: 451–5.
   Google Scholar
• Xu KC, Meng XY, Shi YC, et al. The diagnostic value of a hepatoma-specific band of serum gamma-glutamyl transferase. Int J Cancer 1985; 36: 667–9.
   Google Scholar
• Sacchetti L, Castaldo G, Cimino L, et al. Diagnostic efficiency in discriminating liver malignancies from cirrhosis by serum gamma-glutamyltransferase isoforms. Clin Chim Acta 1988; 177: 167–72.
   Google Scholar
• Yoshikawa C, Shimojo N, Naka K, et al. Separation of hepatoma-associated gamma-glutamyltransferase isoenzyme on cellulose acetate media with Triton X-100 and concanava-lin A. Clin Chim Acta 1989; 185: 317–23.
   Google Scholar
• Xu K, Meng XY, Wu JW, et al. Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study. Am J Gastroenterol 1992; 87: 991–5.
   Google Scholar
• Ohta H, Sawabu N, Kawakami H, et al. Characterisation of g-glutamyltranspeptidase from human hepatocellular carcinoma, compared with enzymes from normal and cirrhotic liver. Clin Chim Acta 1993; 214: 83–92.
   Google Scholar
• Itoh S, Nakajima M. Liver gamma-glutamyltransferase activity in viral liver disease. Digestion 1986; 33: 121–5.
   Google Scholar
• Battezzati PM, Podda M, Bruno S, et al. Factors predicting early response to treatment with recombinant interferon alpha-2a in chronic non-A, non-B hepatitis. Preliminary report of a long-term trial. Ital J Gastroenterol 1992; 24: 481–4.
   Google Scholar
• Camps J, Crisostomo S, Garcia-Granero M, et al. Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables. Gut 1993; 34: 1714–7.
   Google Scholar
• Mazzella G, Salzetta A, Casanova S, et al. Treatment of chronic sporadic-type non-A, non-B hepatitis with lymphoblastoid interferon: gamma GT levels predictive for response. Dig Dis Sci 1994; 39: 866–70.
   Google Scholar
• Chemello L, Cavalletto L, Noventa F, et al. Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon-alpha. J ViralHepat 1995; 2: 91–6.
   Google Scholar
• Olaso V, Cordoba J, Siles MS, et al. Receiver operating characteristics curve analysis of factors predictive of nonresponse to interferon therapy in patients with chronic hepatitis C. Rev Esp Enferm Dig 2000; 92: 495–507.
   Google Scholar
• Van Thiel DH, Friedlander L, Malloy P, et al. gamma-Glutamyl transpeptidase as a response predictor when using alpha-interferon to treat hepatitis C. Hepatogastroenterology 1995; 42: 888–92.
   Google Scholar
• Mihm S, Hartmann H, Fayyazi A, et al. Preferential virological response to interferon-alpha 2a in patients with chronic hepatitis C infected by virus genotype 3a and exhibiting a low gamma-GT/ALT ratio. Dig Dis Sci 1996; 41: 1256–64.
   Google Scholar
• Pawlotsky JM, Roudot-Thoraval F, Bastie A, et al. Factors affecting treatment responses to interferon-alpha in chronic hepatitis C. J Infect Dis 1996; 174: 1–7.
   Google Scholar
• Noventa F, De Salvo GL, Chemello L, et al. A model to predict long-term sustained response to interferon therapy in chronic hepatitis C. J Viral Hepat 1997; 4: 193–7.
   Google Scholar
• Mihm S, Monazahian M, Grethe S, et al. Ratio of g-GT/ALT rather than ISDR variability is predictive for initial virological response to IFN-a in chronic HCV infection. J Med Virol 1999; 58: 227–234.
   Google Scholar
• Piperno A, Sampietro M, D'Alba R, et al. Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C. Liver 1996; 16: 248–54.
   Google Scholar
• Fargion S, Fracanzani AL, Sampietro M, et al. Liver iron influences the response to interferon alpha therapy in chronic hepatitis C. Eur J Gastroenterol Hepatol 1997; 9: 497–503.
   Google Scholar
• Marelli A, Nardecchia L, De Gennaro F, et al. Therapy of chronic hepatitis C with alpha-interferon in 182 patients. Evaluation of results, response predictive factors and side effects. Minerva Med 1999; 90: 405–12.
   Google Scholar
• Benvegnu L, Chemello L, Noventa F, et al. Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis. Cancer 1998; 83: 901–9.
   Google Scholar
• Teschke R, Neuefeind M, Nishimura M, et al. Hepatic gamma-glutamyltransferase activity in alcoholic fatty liver: comparison with other liver enzymes in man and rats. Gut 1983; 24: 625–30.
   Google Scholar
• Satoh T, Takenaga M, Kitagawa H, et al. Microassay of gamma-glutamyl transpeptidase in needle biopsies of human liver. Res Commun Chem Pathol Pharmacol 1980; 30: 151–61.
   Google Scholar
• Selinger MJ, Matloff DS, Kaplan MM. gamma-Glutamyl transpeptidase activity in liver disease: serum elevation is independent of hepatic GGTP activity. Clin Chim Acta 1982 10; 125: 283–90.
   Google Scholar
• Singh S, Shackleton G, Ah-Sing E, et al. Antioxidant defenses in the bile duct-ligated rat. Gastroenterology 1992; 103: 1625–9.
   Google Scholar
• Krahenbuhl S, Talos C, Lauterburg BH, et al. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology 1995; 22: 607–12.
   Google Scholar
• Panozzo MP, Basso D, Balint L, et al. Altered lipid peroxidation/glutathione ratio in experimental extrahepatic cholestasis. Clin Exp Pharmacol Physiol 1995; 22: 266–71.
   Google Scholar
• Pastor A, Collado PS, Almar M, et al. Antioxidant enzyme status in biliary obstructed rats: effects of N-acetylcysteine. J Hepatol 1997; 27: 363–70.
   Google Scholar
• Gonzalez-Correa JA, De La Cruz JP, Martin-Aurioles E, et al. Effects of S-adenosyl-L-methionine on hepatic and renal oxidative stress in an experimental model of acute biliary obstruction in rats. Hepatology 1997; 26: 121–7.
   Google Scholar
• Tsai LY, Lee KT, Lu FJ. Biochemical events associated with ligation of the common bile duct in Wistar rats. J Formos Med Assoc 1997; 96: 17–22.
   Google Scholar
• Purucker E, Winograd R, Roeb E, et al. Glutathione status in liver and plasma during development of biliary cirrhosis after bile duct ligation. Res Exp Med (Berl) 1998; 198: 16774.
   Google Scholar
• Baron V, Muriel P. Role of glutathione, lipid peroxidation and antioxidants on acute bile-duct obstruction in the rat. Biochim Biophys Acta 1999; 1472: 173–80.
   Google Scholar
• Rosalki SB, Tarlow D, Rau D. Plasma gamma-glutamyl transpeptidase elevation in patients receiving enzyme-inducing drugs. Lancet 1971; 2: 376–7
   Google Scholar
• Acheampong-Mensah D. Activity of gamma-glutamyl transpeptidase in serum of patients receiving anticonvulsant of anticoagulant therapy. Clin Biochem 1976; 9: 67–70.
   Google Scholar
• Keeffe EB, Sunderland MC, Gabourel JD. Serum gamma-glutamyl transpeptidase activity in patients receiving chronic phenytoin therapy. Dig Dis Sci 1986; 31: 1056–61.
   Google Scholar
• Braide SA, Davies TJ. Factors that affect the induction of gamma glutamyltransferase in epileptic patients receiving anti-convulsant drugs. Ann Clin Biochem 1987; 24: 391–9.
   Google Scholar
• Aldenhovel HG. Altered gamma-glutamyltransferase, aspartate aminotransferase, alanine ami-notransferase and alkaline phosphatase serum activities in long-term anticonvulsive therapy— comparison of diphenylhydantoin and carbamazepine. Wien Klin Wochenschr 1988; 100: 680–3
   Google Scholar
• Sano J, Kawada H, Yamaguchi N, et al. Effects of phenytoin on serum gamma-glutamyl transpeptidase activity. Epilepsia 1981; 22: 331–8.
   Google Scholar
• de Wolff FA, Peters AC, van Kempen GM. Serum concentrations and enzyme induction in epileptic children treated with phenytoin and valproate. Neuropediatrics 1982; 13: 10–3.
   Google Scholar
• Bartels H, Hauck W, Vogel I. Aminopyrine—an effective modifier of liver and serum gamma glutamyl transpeptidase. J Pediatr 1975; 86: 298–301.
   Google Scholar
• Ohnhaus EE, Gerber-Taras E, Park BK. Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man. Eur J Clin Pharmacol 1983; 24: 247–50.
   Google Scholar
• Kreiss K, Zack MM, Kimbrough RD, et al. Cross-sectional study of a community with exceptional exposure to DDT. JAMA 1981; 245: 1926–30.
   Google Scholar
• Garcia M, Mourelle M. Gamma-glutamyl transpeptidase: a sensitive marker in DDT and toxaphene exposure. J Appl Toxicol 1984; 4: 246–8.
   Google Scholar
• Hildebrandt AG, Roots I, Speck M, et al. Evaluation of in vivo parameters of drug metabolizing enzyme activity in man after administration of clemastine, phenobarbital or placebo. Eur J Clin Pharmacol 1975; 8: 327–36.
   Google Scholar
• Moreland TA, Park BK, Rylance GW. Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity. Br J Clin Pharmacol 1982; 14: 861–5.
   Google Scholar
• Heinemeyer G, Roots I, Lestau P, et al. D-glucaric acid excretion in critical care patients— comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy. Br J Clin Pharmacol 1986; 21: 9–18.
   Google Scholar
• Callaghan N, Majeed T, O'Connell A, et al. A comparative study of serum F protein and other liver function tests as an index of hepatocellular damage in epileptic patients. Acta Neurol Scand 1994; 89: 237–41.
   Google Scholar
• Braide SA. The role of glutathione in the induction of hepatic gamma-glutamyltransferase by phenobarbitone. J Environ Pathol Toxicol Oncol 1989; 9: 317–21.
   Google Scholar
• Braide SA. A requirement for low concentration of hepatic glutathione for induction of gammaglutamyltransferase by phenobarbitone. J Environ Pathol Toxicol Oncol 1989; 9: 42933.
   Google Scholar
• Rosalki SB, Rau D, Lehmann D, et al. Gamma-glutamyl transpeptidase in chronic alcoholism. Lancet 1970; 2: 1139.
   Google Scholar
• Rosalki SB, Rau D. Serum g-glutamyl transpeptidase activity in alcoholism. Clin Chim Acta 1972; 39: 41–7.
   Google Scholar
• Spencer-Peet J, Wood D, Glatt MM. Gamma-glutamyl transpeptidase in alcoholism. Lancet 1972; 1: 1122–3.
   Google Scholar
• Spencer-Peet J, Wood DC, Glatt MM. Screening test for alcoholism. Lancet 1973; 2: 108990.
   Google Scholar
• Rollason JG, Pincherle G, Robinson D. Serum gamma glutamyl transpeptidase in relation to alcohol consumption. Clin Chim Acta 1972; 39: 75–80.
   Google Scholar
• Kristensson H, Trell E, Eriksson S, et al. Serum-gamma-glutamyltransferase in alcoholism. Lancet 1977; 1: 609.
   Google Scholar
• Whitehead TP, Clarke CA, Whitfield AG. Biochemical and haematological markers of alcohol intake. Lancet 1978; 1: 978–81.
   Google Scholar
• Whitfield JB, Hensley WJ, Bryden D, et al. Some laboratory correlates of drinking habits. Ann Clin Biochem 1978; 15: 297–303.
   Google Scholar
• Whitfield JB, Hensley WJ, Bryden D, et al. Estimation of alcohol intake from laboratory results. Ann Clin Biochem 1978; 15: 304–6.
   Google Scholar
• Bagrel A, d'Houtaud A, Gueguen R, et al. Relations between reported alcohol consumption and certain biological variables in an “unselected” population. Clin Chem 1979; 25: 1242–6
   Google Scholar
• Papoz L, Warnet JM, Pequignot G, et al. Alcohol consumption in a healthy population. Relationship to gamma-glutamyl transferase activity and mean corpuscular volume. JAMA 1981; 245: 1748–51.
   Google Scholar
• Chick J, Kreitman N, Plant M. Mean cell volume and gamma-glutamyl-transpeptidase as markers of drinking in working men. Lancet 1981; 1: 1249–51
   Google Scholar
• Nagaya T, Yoshida H, Takahashi H, Matsuda Y, et al. Dose-response relationships between drinking and serum tests in Japanese men aged 40-59 years. Alcohol 1999 Feb. 17(2): 1338.
   Google Scholar
• Salaspuro M. Carbohydrate-deficient transferrin as compared to other markers of alcoholism: a systematic review. Alcohol 1999; 19: 261–71.
   Google Scholar
• Scouller K, Conigrave KM, Macaskill P, et al. Should we use CDT instead of GGT for detecting problem drinkers? A systematic review and meta-analysis. Clin Chem 2000; 46: 1894–1902.
   Google Scholar
• Dunbar JA, Hagart J, Martin B, et al. Drivers, binge drinking, and gammaglutamyltranspeptidase. Br Med J 1982; 285: 1083
   Google Scholar
• Gill GV, Baylis PH, Flear CT, et al. Acute biochemical responses to moderate beer drinking. Br Med J (Clin Res Ed) 1982; 285: 1770–3.
   Google Scholar
• Devgun MS, Dunbar JA, Hagart J, et al. Effects of acute and varying amounts of alcohol consumption on alkaline phosphatase, aspartate transaminase, and gamma-glutamyltransferase. Alcohol Clin Exp Res 1985; 9: 235–7
   Google Scholar
• Freer DE, Statland BE. The effects of ethanol (0.75 g/kg body weight) on the activities of selected enzymes in sera of healthy young adults. I. Intermediate-term effects. Clin Chem 1977; 23: 830–4.
   Google Scholar
• Freer DE, Statland BE. Effects of ethanol (0.75 g/kg body weight) on the activities of selected enzymes in sera of healthy young adults. II. Interindividual variations in response of gamma-glutamyltransferase to repeated ethanol challenges. Clin Chem 1977; 23: 2099–102.
   Google Scholar
• Belfrage P, Berg B, Cronholm T, et al. Prolonged administration of ethanol to young, healthy volunteers: effects on biochemical, morphological and neurophysiological parameters. Acta Med Scand Suppl 1973; 552: 1–44.
   Google Scholar
• Frimpong NA, Lapp JA. Effects of moderate alcohol intake in fixed or variable amounts on concentration of serum lipids and liver enzymes in healthy young men. Am J Clin Nutr 1989; 50: 987–91
   Google Scholar
• Randell E, Diamandis EP, Goldberg DM. Changes in serum carbohydrate-deficient transferrin and gammaglutamyl transferase after moderate wine consumption in healthy males. J Clin Lab Anal 1998; 12: 92–7.
   Google Scholar
• Salmela KS, Laitinen K, Nystrom M, et al. Carbohydrate-deficient transferrin during 3 weeks heavy alcohol consumption. Alcohol Clin Exp Res 1994; 18: 228–30.
   Google Scholar
• Nemesanszky E, Lott JA, Arato M. Changes in serum enzymes in moderate drinkers after an alcohol challenge. Clin Chem 1988; 34: 525–7.
   Google Scholar
• Lamy J, Baglin MC, Ferrant JP, et al. Decrease in serum gamma-glutamyltranspeptidase following abstention from alcohol. Clin Chim Acta 1974; 56: 169–73.
   Google Scholar
• Lamy J, Baglin MC, Aron E, et al. Decrease in serum gamma-glutamyltranspeptidase following abstention from alcohol in cirrhotics. Clin Chim Acta 1975; 60: 97–101.
   Google Scholar
• Orrego H, Blake JE, Israel Y. Relationship between gamma-glutamyl transpeptidase and mean urinary alcohol levels in alcoholics while drinking and after alcohol withdrawal. Alcohol Clin Exp Res 1985; 9: 10–3.
   Google Scholar
• Moussavian SN, Becker RC, Piepmeyer JL, et al. Serum gamma-glutamyl transpeptidase and chronic alcoholism. Influence of alcohol ingestion and liver disease. Dig Dis Sci 1985; 30: 211–4.
   Google Scholar
• Matsuda Y, Tsuchishima M, Ueshima Y, et al. The relationship between the development of alcoholic liver and pancreatic diseases and the induction of gamma glutamyl transferase. Alcohol Alcohol Suppl 1993; 1B: 27–33.
   Google Scholar
• Monteiro MG, Masur J. Monitoring alcoholism treatment: the appropriateness of choice between gamma GT or MCV evaluation after a short time of abstinence. Alcohol 1986; 3: 223–6.
   Google Scholar
• Pol S, Poynard T, Bedossa P, et al. Diagnostic value of serum gamma-glutamyl-transferase activity and mean corpuscular volume in alcoholic patients with or without cirrhosis. Alcohol Clin Exp Res 1990; 14: 250–4.
   Google Scholar
• Weill J, Schellenberg F, Le Goff AM, et al. The decrease of low serum gamma glutamyl transferase during short-term abstinence. Alcohol 1988; 5: 1–3.
   Google Scholar
• Helander A, Carlsson AV, Borg S. Longitudinal comparison of carbohydrate-deficient transferrin and gamma-glutamyl transferase: complementary markers of excessive alcohol consumption. Alcohol Alcohol 1996; 31: 101–7.
   Google Scholar
• Lijmer JG, Mol BW, Heisterkamp S, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999; 282: 1061–6.
   Google Scholar
• Hoeksema HL, de Bock GH. The value of laboratory tests for the screening and recognition of alcohol abuse in primary care patients. J Fam Pract 1993; 37: 268–76.
   Google Scholar
• Conigrave KM, Saunders JB, Whitfield JB. Diagnostic tests for alcohol consumption. Alcohol Alcohol 1995; 30: 13–26.
   Google Scholar
• Levine J. The relative value of consultation, questionnaires and laboratory investigation in the identification of excessive alcohol consumption. Alcohol Alcohol 1990; 25: 539–53.
   Google Scholar
• Bernadt MW, Mumford J, Taylor C, et al. Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism. Lancet 1982; 1: 325–8.
   Google Scholar
• Dobkin P, Dongier M, Cooper D, et al. Screening for alcoholism in a psychiatric hospital. Can J Psychiatry 1991; 36: 39–45.
   Google Scholar
• Wetterling T, Kanitz RD, Rumpf HJ, et al. Comparison of cage and mast with the alcohol markers CDT, gamma-GT, ALAT, ASAT and MCV. Alcohol Alcohol 1998; 33: 424–30.
   Google Scholar
• Vanclay F, Raphael B, Dunne M, et al. A community screening test for high alcohol consumption using biochemical and haematological measures. Alcohol Alcohol 1991; 26: 337–46.
   Google Scholar
• Rivara FP, Koepsell TD, Jurkovich GJ, et al. The effects of alcohol abuse on readmission for trauma. JAMA 1993; 270: 1962–4.
   Google Scholar
• Meerkerk GJ, Njoo KH, Bongers IM, et al. Comparing the diagnostic accuracy of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean cell volume in a general practice population. Alcohol Clin Exp Res 1999; 23: 1052–9.
   Google Scholar
• Sillanaukee P, Aalto M, Seppa K. Carbohydrate-deficient transferrin and conventional alcohol markers as indicators for brief intervention among heavy drinkers in primary health care. Alcohol Clin Exp Res 1998; 22: 892–6.
   Google Scholar
• Anton RF, Stout RL, Roberts JS, et al. The effect of drinking intensity and frequency on serum carbohydrate-deficient transferrin and gamma-glutamyl transferase levels in outpatient alcoholics. Alcohol Clin Exp Res 1998; 22: 1456–62.
   Google Scholar
• Litten RZ, Allen JP, Fertig JB. Gamma-glutamyltranspeptidase and carbohydrate deficient transferrin: alternative measures of excessive alcohol consumption. Alcohol Clin Exp Res 1995; 19: 1541–6.
   Google Scholar
• Huseby NE, Nilssen O, Kanitz RD. Evaluation of two biological markers combined as a parameter of alcohol dependency. Alcohol Alcohol 1997; 32: 731–7.
   Google Scholar
• Sillanaukee P, Massot N, Jousilahti P, et al. Enhanced clinical utility of gamma-CDT in a general population. Alcohol Clin Exp Res 2000; 24: 1202–6.
   Google Scholar
• Borg S. Treatment of alcohol dependence: experiences of using biological markers in monitoring and prevention of relapse. Alcohol Alcohol 1996; 31: 621–4.
   Google Scholar
• Persson J, Magnusson PH. Early intervention in patients with excessive consumption of alcohol: a controlled study. Alcohol 1989; 6: 403–8.
   Google Scholar
• Nilssen O. The Tromso Study: identification of and a controlled intervention on a population of early-stage risk drinkers. Prev Med 1991; 20: 518–28.
   Google Scholar
• Tomson Y, Romelsjo A, Aberg H. Excessive drinking—brief intervention by a primary health care nurse. A randomized controlled trial. Scand J Prim Health Care 1998; 16: 188–92.
   Google Scholar
• Lhuintre JP, Moore N, Tran G, et al. Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol Alcohol 1990; 25: 613–22
   Google Scholar
• Chick J, Anton R, Checinski K, et al. Multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol 2000; 35: 587–93.
   Google Scholar
• Niederau C, Niederau M, Strohmeyer G, et al. Does acute consumption of large alcohol amounts lead to pancreatic injury? A prospective study of serum pancreatic enzymes in 300 drunken drivers. Digestion 1990; 45: 115–20.
   Google Scholar
• Dunbar JA, Ogston SA, Ritchie A, et al. Are problem drinkers dangerous drivers? An investigation of arrest for drinking and driving, serum gamma glutamyltranspeptidase activities, blood alcohol concentrations, and road traffic accidents: the Tayside Safe Driving Project. Br Med J (Clin Res Ed) 1985; 290: 827–30.
   Google Scholar
• Irwin M, Smith TL, Butters N, et al. Graded neuropsychological impairment and elevated gamma-glutamyl transferase in chronic alcoholic men. Alcohol Clin Exp Res 1989; 13: 99103.
   Google Scholar
• Richardson ED, Malloy PF, Longabaugh R, et al. Liver function tests and neuropsychologic impairment in substance abusers. Addictive Behaviors 1991; 16: 51–55.
   Google Scholar
• Gjerde H, Sakshaug J, Morland J. Heavy drinking among Norwegian male drunken drivers: a study of gamma-glutamyltransferase. Alcohol Clin Exp Res 1986; 10: 209–12.
   Google Scholar
• Gjerde H, Morland J. A two-year prospective study of rearrests for drunken driving. Scand J Soc Med 1988; 16: 111–3.
   Google Scholar
• Kristenson H, Ohrn J, Hood B. Convictions for drunkenness or drunken driving, sick absenteeism, and morbidity in middle-aged males with different levels of serum gamma-glutamyltransferase. Prev Med 1982; 11: 403–16.
   Google Scholar
• Larsson G, Ottenblad C, Hagenfeldt L, et al. Evaluation of serum gamma-glutamyl transferase as a screening method for excessive alcohol consumption during pregnancy. Am J Obstet Gynecol 1983; 147: 654–7.
   Google Scholar
• Ylikorkala O, Stenman UH, Halmesmaki E. gamma-Glutamyl transferase and mean cell volume reveal maternal alcohol abuse and fetal alcohol effects. Am J Obstet Gynecol 1987; 157: 344–8.
   Google Scholar
• Halmesmaki E, Roine R, Salaspuro M. Gamma-glutamyltransferase, aspartate and alanine aminotransferases and their ratio, mean cell volume and urinary dolichol in pregnant alcohol abusers. Br J Obstet Gynaecol 1992; 99: 287–91.
   Google Scholar
• Sarkola T, Eriksson CJ, Niemela O, et al. Mean cell volume and gamma-glutamyl transferase are superior to carbohydrate-deficient transferrin and hemoglobin-acetaldehyde adducts in the follow-up of pregnant women with alcohol abuse. Acta Obstet Gynecol Scand2000; 79: 35966.
   Google Scholar
• Stoler JM, Huntington KS, Peterson CM, et al. The prenatal detection of significant alcohol exposure with maternal blood markers. J Pediatr 1998; 133: 346–52.
   Google Scholar
• Whitfield JB, Hensley WJ, Bryden D, et al. Effects of age and sex on biochemical responses to drinking habits. Med J Aust 1978; 2: 629–32.
   Google Scholar
• Whitfield JB, Allen JK, Adena M, et al. A multivariate assessment of alcohol consumption. Int J Epidemiol 1981; 10: 281–8.
   Google Scholar
• Hollstedt C, Dahlgren L. Peripheral markers in the female “hidden alcoholic”. Acta Psychiatr Scand 1987; 75: 591–6.
   Google Scholar
• Yeastedt J, La Grange L, Anton RF. Female alcoholic outpatients and female college students: a correlational study of self-reported alcohol consumption and carbohydrate-deficient transferrin levels. J Stud Alcohol 1998; 59: 555–9.
   Google Scholar
• Anton RF, Moak DH. Carbohydrate-deficient transferrin and gamma-glutamyltransferase as markers of heavy alcohol consumption: gender differences. Alcohol Clin Exp Res 1994; 18: 747–54.
   Google Scholar
• Nilssen O, Huseby NE, Hoyer G, et al. New alcohol markers—how useful are they in population studies: the Svalbard Study 1988-89. Alcohol Clin Exp Res 1992; 16: 82–6.
   Google Scholar
• Nystrom M, Perasalo J, Pikkarainen J, et al. Conventional laboratory tests as indicators of heavy drinking in young university students. Scand J Prim Health Care 1993; 11: 44–9.
   Google Scholar
• Bisson JI, Milford-Ward A. A comparison of carbohydrate deficient transferrin with other markers of alcohol misuse in male soldiers under the age of thirty. Alcohol Alcohol 1994; 29: 315–21.
   Google Scholar
• Nakajima T, Ohta S, Fujita H, et al. Carbohydrate-related regulation of the ethanol-induced increase in serum gamma-glutamyl transpeptidase activity in adult men. Am J Clin Nutr 1994; 60: 87–92.
   Google Scholar
• Clarke M, Ahmed N, Romaniuk H, et al. Ethnic differences in the consequences of alcohol misuse. Alcohol Alcohol 1990; 25: 9–11.
   Google Scholar
• Wickramasinghe SN, Corridan B, Izaguirre J, et al. Ethnic differences in the biological consequences of alcohol abuse: a comparison between south Asian and European males. Alcohol Alcohol 1995; 30: 675–80.
   Google Scholar
• Takeshita T, Yang X, Morimoto K. The ALDH2 genotype, alcohol intake, and liver-function biomarkers among Japanese male workers. Hum Genet 2000; 106: 589–93.
   Google Scholar
• Wu A, Slavin G, Levi AJ. Elevated serum gamma glutamyl transferase (transpeptidase) and histological liver damage in alcoholism. Am J Gastroenterol 1976; 65: 318–323.
   Google Scholar
• Kryszewski A, Bardzik I, Kilkowska K, et al. Gamma glutamyl transpeptidase activity in serum and liver in chronic alcoholism. Acta Medica Polonica 1977; 18: 199–211.
   Google Scholar
• Frezza M, Pozzato G, Chiesa L, et al. Abnormal serum gamma-glutamyltranspeptidase in alcoholics. Clues to its explanation. Neth J Med 1989; 34: 22–28.
   Google Scholar
• Whitfield JB, Allen JK, Adena MA, et al. Effect of drinking on correlations between biochemical variables. Ann Clin Biochem 1981; 18: 143–5.
   Google Scholar
• Tutor JC, Alvarez-Prechous A, Bernabeu F, et al. Urinary D-glucaric acid and serum hepatic enzyme levels in chronic alcoholics. Clin Biochem 1988; 21: 193–8
   Google Scholar
• Allaway SL, Ritchie CD, Robinson D, et al. Detection of alcohol-induced fatty liver by computerized tomography. JR Soc Med 1988; 81: 149–51.
   Google Scholar
• Ivanov E, Adjarov D, Etarska M, et al. Elevated liver gamma-glutamyl transferase in chronic alcoholics. Enzyme 1980; 25: 304–8.
   Google Scholar
• Yamauchi M, Kimura K, Kawase H, et al. Hepatic gamma-glutamyl transferase and hepatic fibrosis in patients with alcoholic liver disease. Enzyme 1984; 32: 110–5.
   Google Scholar
• Ishii H, Ebihara Y, Okuno F, et al. Gamma-glutamyl transpeptidase activity in liver of alcoholics and its localization. Alcohol Clin Exp Res 1986; 10: 81–5
   Google Scholar
• Seitz HK, Velasquez D, Waldherr R, et al. Duodenal gamma-glutamyltransferase activity in human biopsies: effect of chronic ethanol consumption and duodenal morphology. Eur J Clin Invest 1985; 15: 192–6.
   Google Scholar
• Ishii H, Watanabe Y, Okuno F, et al. Alcohol-induced enhancement of intestinal gamma-glutamyl transpeptidase activity in rats and humans: a possible role in increased serum gamma-glutamyl transpeptidase activity in alcoholics. Alcohol Clin Exp Res 1988; 12: 111–5.
   Google Scholar
• Hauge T, Nilsson A, Persson J, et al. Gamma-glutamyl transferase, intestinal alkaline phos-phatase and beta-hexosaminidase activity in duodenal biopsies from chronic alcoholics. Hepatogastroenterology 1998; 45: 985–9.
   Google Scholar
• Ishii H, Okuno F, Shigeta Y, et al. Significance of serum gamma glutamyl transpeptidase as a marker of alcoholism. Pharmacol Biochem Behav 1980; 13 Suppl 1: 95–9.
   Google Scholar
• Nishimura M, Stein H, Berges W, et al. Gamma-glutamyltransferase activity of liver plasma membrane: induction following chronic alcohol consumption. Biochem Biophys Res Commun 1981 16; 99: 142–8.
   Google Scholar
• Halsall S, Peters TJ. Effect of chronic ethanol consumption on the cellular and subcellular distribution of gamma-glutamyltransferase in rat liver. Enzyme 1984; 31: 221–8.
   Google Scholar
• Rambabu K, Matsuda Y, Katunuma N. Studies on turnover rates of rat gamma-glutamyltranspeptidase after chronic ethanol administration in vivo. Biochem Med Metab Biol 1986; 35: 335–44.
   Google Scholar
• Barouki R, Chobert MN, Finidori J, et al. Ethanol effects in a rat hepatoma cell line: induction of gamma-glutamyltransferase. Hepatology 1983; 3: 323–9.
   Google Scholar
• Odoul M, Bagrel D, Peyrieras N, et al. Glycosylation of gamma-glutamyltransferase is modified by ethanol in H5-6 hepatoma cell line. Clin Chim Acta 1994; 225: 1–15.
   Google Scholar
• Tescheke R, Petrides AS. Hepatic gamma-glutamyltransferase activity: its increase following chronic alcohol consumption and the role of carbohydrates. Biochem Pharmacol 1982; 23: 3751–3756
   Google Scholar
• Misslbeck NG, Campbell TC, Roe DA. Increase in hepatic gamma-glutamyltransferase (GGT) activity following chronic ethanol intake in combination with a high fat diet. Biochem Pharmacol 1986; 35: 399–404.
   Google Scholar
• Yamada S, Wilson JS, Lieber CS. The effects of ethanol and diet on hepatic and serum gamma-glutamyltranspeptidase activities in rats. J Nutr 1985; 115: 1285–90.
   Google Scholar
• Speisky H, Gunasekara A, Varghese G, et al. Basolateral gamma-glutamyl transferase ectoactivity in rat liver: effects of chronic alcohol consumption. Alcohol Alcohol 1987; Suppl 1: 245–9.
   Google Scholar
• Speisky H, Israel Y. Gamma-glutamyl transferase ectoactivity in the intact rat liver: effect of chronic alcohol consumption. Alcohol 1990; 7: 339–47.
   Google Scholar
• Morton S, Mitchell MC. Effects of chronic ethanol feeding on glutathione turnover in the rat. Biochem Pharmacol 1985; 34: 1559–63.
   Google Scholar
• Pierson JL, Mitchell MC. Increased hepatic efflux of glutathione after chronic ethanol feeding. Biochem Pharmacol 1986; 35: 1533–7.
   Google Scholar
• Callans DJ, Wacker LS, Mitchell MC. Effects of ethanol feeding and withdrawal on plasma glutathione elimination in the rat. Hepatology 1987; 7: 496–501
   Google Scholar
• Fernandez-Checa JC, Ookhtens M, Kaplowitz N. Effect of chronic ethanol feeding on rat hepatocytic glutathione. Compartmentation, efflux, and response to incubation with ethanol. J Clin Invest 1987; 80: 57–62.
   Google Scholar
• Fernandez-Checa JC, Ookhtens M, Kaplowitz N. Effects of chronic ethanol feeding on rat hepatocytic glutathione. Relationship of cytosolic glutathione to efflux and mitochondrial sequestration. J Clin Invest 1989; 83: 1247–52.
   Google Scholar
• Fernandez-Checa JC, Garcia-Ruiz C, Ookhtens M, et al. Impaired uptake of glutathione by hepatic mitochondria from chronic ethanol-fed rats. Tracer kinetic studies in vitro and in vivo and susceptibility to oxidant stress. J Clin Invest 1991; 87: 397–405.
   Google Scholar
• Garcia-Ruiz C, Morales A, Ballesta A, et al. Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal and perivenous rat hepatocytes. J Clin Invest 1994; 94: 193–201.
   Google Scholar
• Battiston L, Moretti M, Tulissi P, et al. Hepatic glutathione determination after ethanol administration in rat: evidence of the first-pass metabolism of ethanol. Life Sci 1995; 56: 241–8.
   Google Scholar
• Kristenson H, Ohrn J, Trell E, et al. Serum gamma-glutamyltransferase at screening and retrospective sickness days. Lancet 1980; 1: 1141.
   Google Scholar
• Peterson B, Trell E, Kristensson H, et al. Comparison of gamma-glutamyltransferase and other health screening tests in average middle-aged males, heavy drinkers and alcohol non-users. Scand J Clin Lab Invest 1983; 43: 141–9.
   Google Scholar
• Kristenson H, Ohlin H, Hulten-Nosslin MB, et al. Identification and intervention of heavy drinking in middle-aged men: results and follow-up of 24-60 months of long-term study with randomized controls. Alcohol Clin Exp Res 1983; 7: 203–9.
   Google Scholar
• Hood B, Kjellstrom T, Ruter G, et al. Serum cholesterol, serum triglyceride, alcohol, myocar-dial infarction and death (2): necessary to pay attention to serum GT in assessment of risks of myocardial infarction and death. Lakartidningen 1990; 87: 3295–8.
   Google Scholar
• Conigrave KM, Saunders JB, Reznik RB, et al. Prediction of alcohol-related harm by laboratory test results. Clinical Chemistry 1993; 39: 2266–2270.
   Google Scholar
• Brenner H, Rothenbacher D, Arndt V, et al. Distribution, determinants, and prognostic value of gamma-glutamyltransferase for all-cause mortality in a cohort of construction workers from southern Germany. Prev Med 1997; 26: 305–10.
   Google Scholar
• Arndt Y, Brenner H, Rothenbacher D, et al. Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality. Int Arch Occup Environ Health 1998; 71: 405–12.
   Google Scholar
• Karlson BW, Wiklund O, Hallgren P, et al. Ten-year mortality among patients with a very small or unconfirmed acute myocardial infarction in relation to clinical history, metabolic screening and signs of myocardial ischaemia. J Intern Med 2000; 247: 449–56.
   Google Scholar
• Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995; 142: 699–708.
   Google Scholar
• Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 1998; 21: 732–7.
   Google Scholar
• Miura K, Nakagawa H, Nakamura H, et al. Serum gamma-glutamyl transferase level in predicting hypertension among male drinkers. J Hum Hypertens 1994; 8: 445–9
   Google Scholar
• Jousilahti P, Rastenyte D, Tuomilehto J. Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke 2000; 31: 1851–5.
   Google Scholar
• Arnesen E, Huseby NE, Brenn T, et al. The Tromso Heart Study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population. Scand J Clin Lab Invest 1986; 46: 63–70.
   Google Scholar
• Nilssen O, Forde OH, Brenn T. The Tromso Study. Distribution and population determinants of gamma-glutamyltransferase. Am J Epidemiol 1990; 132: 318–26.
   Google Scholar
• Robinson D, Whitehead TP. Effect of body mass and other factors on serum liver enzyme levels in men attending for well population screening. Ann Clin Biochem 1989; 26: 393–400
   Google Scholar
• Salvaggio A, Periti M, Miano L, et al. Body mass index and liver enzyme activity in serum. Clin Chem 1991; 37: 720–3.
   Google Scholar
• Nomura F, Ohnishi K, Satomura Y, et al. Liver function in moderate obesity—study in 534 moderately obese subjects among 4613 male company employees. Int J Obes 1986; 10: 34954.
   Google Scholar
• Ikai E, Honda R, Yamada Y. Serum gamma-glutamyl transpeptidase level and blood pressure in nondrinkers: a possible pathogenetic role of fatty liver in obesity-related hypertension. J Hum Hypertens 1994; 8: 95–100.
   Google Scholar
• Pintus F, Mascia P. Distribution and population determinants of gamma-glutamyltransferase in a random sample of Sardinian inhabitants. 'ATS-SARDEGNA' Research Group. Eur J Epidemiol 1996; 12: 71–6.
   Google Scholar
• Daeppen JB, Smith TL, Schuckit MA. Influence of age and body mass index on gamma-glutamyltransferase activity: a 15-year follow-up evaluation in a community sample. Alcohol Clin Exp Res 1998; 22: 941–4.
   Google Scholar
• van Barneveld T, Seidell JC, Traag N, et al. Fat distribution and gamma-glutamyl transferase in relation to serum lipids and blood pressure in 38-year-old Dutch males. Eur J Clin Nutr 1989; 43: 809–18.
   Google Scholar
• Poikolainen K, Vartiainen E. Determinants of gamma-glutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee. Am J Epidemiol 1997; 146: 1019–24.
   Google Scholar
• Kornhuber HH, Backhaus B, Kornhuber AW, et al. The main cause of diabetes (type II): “normal” alcohol drinking. Versicherungsmedizin 1990; 42: 132, 134–42.
   Google Scholar
• Yamada Y, Ishizaki M, Kido T, et al. Relationship between serum gamma-glutamyl transpeptidase activity, blood pressure and alcohol consumption. J Hum Hypertens 1989; 3: 409–17.
   Google Scholar
• Yamada Y, Ishizaki M, Kido T, et al. Relationship between serum gamma-glutamyl transpeptidase activity and blood pressure in middle-aged male and female non-drinkers. J Hum Hypertens 1990; 4: 609–14.
   Google Scholar
• Yamada Y, Ikai E, Tsuritani I, et al. The relationship between serum gamma-glutamyl transpeptidase levels and hypertension: common in drinkers and nondrinkers. Hypertens Res 1995; 18: 295–301.
   Google Scholar
• Ikai E, Ishizaki M, Suzuki Y, et al. Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people. J Hum Hypertens 1995; 9: 101–5.
   Google Scholar
• Martin PJ, Martin JV, Goldberg DM. Gamma-glutamyl transpeptidase, triglycerides, and enzyme induction. Br Med J 1975; 1: 17–8.
   Google Scholar
• Martin JV, Hague RV, Martin PJ, et al. The association between serum triglycerides and gamma glutamyl transpeptidase activity in diabetes mellitus. Clin Biochem 1976; 9: 208–11.
   Google Scholar
• Fex G, Kristenson H, Trell E. Correlations of serum lipids and lipoproteins with gamma-glutamyltransferase and attitude to alcohol consumption. Ann Clin Biochem 1982; 19: 345–9.
   Google Scholar
• Janzon L, Franzen J, Lindell SE, et al. Blood lipid variability in relation to relative weight and biochemical markers of tobacco and alcohol consumption. Postgrad Med J1985; 61: 505–8.
   Google Scholar
• Nikkari ST, Koivu TA, Kalela A, et al. Association of carbohydrate-deficient transferrin (CDT) and gamma-glutamyl-transferase (GGT) with serum lipid profile in the Finnish population. Atherosclerosis 2001; 154: 485–492.
   Google Scholar
• Colloredo-Mels G, Bettale G, Bellati G, et al. gamma-Glutamyl-transpeptidase in diabetics: a case control study. Clin Chim Acta 1988 15; 175: 189–95.
   Google Scholar
• Orrell JM, Neithercut WD, Henderson J, et al. Raised liver associated enzyme activity and post-prandial bile acid concentrations in sera from treated diabetic outpatients. Diabetes Res Clin Pract 1990; 10: 51–7.
   Google Scholar
• Barbieux JP, Bacq Y, Schellenberg F, et al. Increase of serum gamma-glutamyl transferase activity in diabetic patients is not linked to diabetes itself. Pathol Biol (Paris) 1990; 38: 938.
   Google Scholar
• Umeki S, Hisamoto N, Hara Y. Study on background factors associated with impaired glucose tolerance and/or diabetes mellitus. Acta Endocrinol (Copenhagen) 1989; 120: 729–34.
   Google Scholar
• Shoukry MI. Gamma glutamyl transferase in diabetic rats. The effect of insulin treatment. Acta Diabetol Lat 1988; 25: 299–302.
   Google Scholar
• McLennan SV, Heffernan S, Wright L, et al. Changes in hepatic glutathione metabolism in diabetes. Diabetes 1991; 40: 344–8.
   Google Scholar
• Hemmings SJ, Pekush RD. The impact of type I diabetes on rat liver gamma-glutamyltranspeptidase. Mol Cell Biochem 1994; 139: 131–40.
   Google Scholar
• Watkins JB, Klaunig JE, Smith HM, et al. Streptozotocin-induced diabetes increases gamma-glutamyltranspeptidase activity but not expression in rat liver. J Biochem Mol Toxicol 1998; 12: 219–25.
   Google Scholar
• Trell E, Kristenson H, Peterson B, et al. Two-hour glucose and insulin responses after a standardized oral glucose load in relation to serum gamma-glutamyl transferase and alcohol consumption. Acta Diabetol Lat 1981; 18: 311–7.
   Google Scholar
• Kornhuber J, Kornhuber HH, Backhaus B, et al. The normal values of gamma-glutamyltransferase are falsely defined up to now: on the diagnosis of hypertension, obesity and diabetes with reference to “normal” consumption of alcohol. Versicherungsmedizin 1989; 41: 78–81.
   Google Scholar
• Rantala AO, Lilja M, Kauma H, et al. Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med 2000; 248: 230–8.
   Google Scholar
• Wannamethee SG, Shaper AG, Alberti KG. Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes. Arch Intern Med 2000; 160: 210816.
   Google Scholar
• Whitehead TP, Robinson D, Allaway SL. The effects of cigarette smoking and alcohol consumption on serum liver enzyme activities: a dose-related study in men. Ann Clin Biochem 1996; 33: 530–5.
   Google Scholar
• Steffensen FH, Sorensen HT, Brock A, et al. Alcohol consumption and serum liver-derived enzymes in a Danish population aged 30 to 50 years. Int J Epidemiol 1997; 26: 92–9.
   Google Scholar
• Kristenson H, Fex G, Trell E Serum ferritin, gammaglutamyl-transferase and alcohol consumption in healthy middle-aged men. Drug Alcohol Depend 1981; 8: 43–50.
   Google Scholar
• Nystrom E, Bengtsson C, Lindstedt G, et al. Serum gamma-glutamyltransferase in a Swedish female population. Age-related reference intervals; morbidity and prognosis in cases with raised catalytic concentration. Acta Med Scand 1988; 224: 79–84.
   Google Scholar
• Kiechl S, Willeit J, Egger G, et al. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997; 96: 3300–7.
   Google Scholar
• Danesh J, Appleby P. Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 1999 23; 99: 852–4.
   Google Scholar
• Roest M, van der Schouw YT, de Valk B, et al. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 1999; 100: 1268–73.
   Google Scholar
• Tuomainen TP, Kontula K, Nyyssonen K, et al. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland. Circulation 1999; 100: 1274–9.
   Google Scholar
• Casiglia E, Spolaore P, Ginocchio G, et al. Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol 1993; 9: 293–7.
   Google Scholar
• Nilssen O, Forde OH. Seven-year longitudinal population study of change in gamma-glutamyltransferase: the Tromso Study. Am J Epidemiol 1994; 139: 787–92.
   Google Scholar
• Kono S, Shinchi K, Imanishi K, et al. Coffee and serum gamma-glutamyltransferase: a study of self-defense officials in Japan. Am J Epidemiol 1994; 139: 723–7.
   Google Scholar
• Aubin HJ, Laureaux C, Zerah F, et al. Joint influence of alcohol, tobacco, and coffee on biological markers of heavy drinking in alcoholics. Biol Psychiatry 1998; 44: 638–43.
   Google Scholar
• Tanaka K, Tokunaga S, Kono S, et al. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 1998; 27: 438–43.
   Google Scholar
• Honjo S, Kono S, Coleman MP, et al. Coffee drinking and serum gamma-glutamyltransferase: an extended study of Self-Defense Officials of Japan. Ann Epidemiol 1999; 9: 325–31.
   Google Scholar
• Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450–5.
   Google Scholar
• Cortez-Pinto H, Camilo ME, Baptista A, et al. Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr 1999; 18: 353–8.
   Google Scholar
• Luyckx FH, Lefebvre PJ, Scheen AJ. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab 2000; 26: 98–106.
   Google Scholar
• Knobler H, Schattner A, Zhornicki T, et al. Fatty liver—an additional and treatable feature of the insulin resistance syndrome. QJM 1999; 92: 73–9.
   Google Scholar
• Kral JG, Schaffner F, Pierson RN, et al. Body fat topography as an independent predictor of fatty liver. Metabolism 1993; 42: 548–51.
   Google Scholar
• Blazovics A, Feher E, Feher J. Role of free radical reactions in experimental hyperlipidaemia in the pathomechanism of fatty liver. In: Csomos G, Feher J, eds. Free Radicals and the Liver. Pp. 96–123. Berlin, Springer-Verlag, 1992
   Google Scholar